These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8582665)

  • 1. Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia.
    Nacítarhan S; Ozben T; Tuncer N
    Free Radic Biol Med; 1995 Dec; 19(6):893-6. PubMed ID: 8582665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and urine malondialdehyde levels in non-insulin-dependent diabetic patients with and without microalbuminuria.
    Ozben T; Nacitarhan S; Tuncer N
    Int J Clin Lab Res; 1995; 25(3):162-4. PubMed ID: 8562981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides.
    Guerci B; Antebi H; Meyer L; Durlach V; Ziegler O; Nicolas JP; Alcindor LG; Drouin P
    Clin Chem; 1999 Sep; 45(9):1439-48. PubMed ID: 10471646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lipid peroxidation and oxidative DNA damage in patients with periodontitis and hyperlipidemia.
    Fentoğlu Ö; Kırzıoğlu FY; Bulut MT; Kumbul Doğuç D; Kulaç E; Önder C; Günhan M
    J Periodontol; 2015 May; 86(5):682-8. PubMed ID: 25612631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation in type 2 normolipidemic diabetic patients.
    Freitas JP; Filipe PM; Rodrigo FG
    Diabetes Res Clin Pract; 1997 May; 36(2):71-5. PubMed ID: 9229190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma malondialdehyde (MDA) and anti-oxidant status in diabetic retinopathy.
    Kumawat M; Kharb S; Singh V; Singh N; Singh SK; Nada M
    J Indian Med Assoc; 2014 Jan; 112(1):29-32. PubMed ID: 25935946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gingival crevicular fluid oxidative stress level in patients with periodontal disease and hyperlipidemia.
    Lutfioğlu M; Aydoğdu A; Atabay VE; Sakallioğlu EE; Avci B
    Braz Oral Res; 2017 Dec; 31():e110. PubMed ID: 29267671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia.
    Dunn FL; Raskin P; Bilheimer DW; Grundy SM
    Metabolism; 1984 Feb; 33(2):117-23. PubMed ID: 6582347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in families of type 1 diabetic patients.
    Matteucci E; Giampietro O
    Diabetes Care; 2000 Aug; 23(8):1182-6. PubMed ID: 10937519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of olbetam on hyperlipidemia in NIDDM].
    Yu Y; Liang J; Zhang X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):427-9. PubMed ID: 8732067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased lipid peroxidation in type 2 poorly controlled diabetic patients.
    Altomare E; Vendemiale G; Chicco D; Procacci V; Cirelli F
    Diabete Metab; 1992; 18(4):264-71. PubMed ID: 1459313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin reduces triglyceride, VLDL and cholesterol/HDL levels in hyperlipidemic diabetic patients on hemodialysis.
    Yang C; Wu T; Huang C
    Am J Nephrol; 1998; 18(5):384-90. PubMed ID: 9730561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma malondialdehyde levels and risk factors for the development of chronic complications in type 2 diabetic patients on insulin therapy.
    Kaefer M; De Carvalho JA; Piva SJ; da Silva DB; Becker AM; Sangoi MB; Almeida TC; Hermes CL; Coelho AC; Tonello R; Moreira AP; Garcia SC; Moretto MB; Moresco RN
    Clin Lab; 2012; 58(9-10):973-8. PubMed ID: 23163113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma malondialdehyde in type 1 and type 2 diabetic patients.
    Gallou G; Ruelland A; Legras B; Maugendre D; Allannic H; Cloarec L
    Clin Chim Acta; 1993 Feb; 214(2):227-34. PubMed ID: 8472388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease.
    Dyer RG; Stewart MW; Mitcheson J; George K; Alberti MM; Laker MF
    Clin Chim Acta; 1997 Apr; 260(1):1-13. PubMed ID: 9101096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous Humour and Serum Levels of Nitric Oxide, Malondialdehyde and Total Antioxidant Status in Patients with Type 2 Diabetes with Proliferative Diabetic Retinopathy and Nondiabetic Senile Cataracts.
    Kulaksızoglu S; Karalezli A
    Can J Diabetes; 2016 Apr; 40(2):115-9. PubMed ID: 26388409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of proteinuria following correction of hyperlipidemia in NIDDM patients with nondiabetic glomerulopathy.
    Dubois D; Chanson P; Timsit J; Chauveau D; Nochy D; Guillausseau PJ; Lubetzki J
    Diabetes Care; 1994 Aug; 17(8):906-8. PubMed ID: 7956642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus.
    Pasaoglu H; Sancak B; Bukan N
    Tohoku J Exp Med; 2004 Jul; 203(3):211-8. PubMed ID: 15240931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of lipid peroxidation with antenatal betamethasone and oxygen radial disorders in preterm infants.
    Weinberger B; Anwar M; Henien S; Sosnovsky A; Hiatt M; Jochnowitz N; Witz G; Hegyi T
    Biol Neonate; 2004; 85(2):121-7. PubMed ID: 14631157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients.
    Mahboob M; Rahman MF; Grover P
    Singapore Med J; 2005 Jul; 46(7):322-4. PubMed ID: 15968442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.